Hjem › Lupus › New York › New York City
Kliniske studier for Lupus i New York City, NY
18 studier for Lupus søker deltakere på steder i og rundt New York City (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases
RekruttererFase 2
- Columbia University Medical Center, New York
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
RekruttererFase 1
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- NYP/Weill Cornell Medical Center, New York
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
RekruttererFase 3
- Sl0044 50077, New York
An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants
RekruttererFase 3
- Research Site, New York
HEALTH Home Urinalysis Testing
Rekrutterer
- NYU Langone Health, New York
A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE
RekruttererFase 1/2
- Research Site, New York
A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
RekruttererFase 1
- Icahn School of Medicine at Mount Sinai, New York
A Study to Continue the Administration of Deucravacitinib in Participants With Systemic Lupus Erythematosus (SLE) or Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE) Who Have Completed Study IM011074 or Study IM011132
RekruttererFase 4
- New York University School Of Medicine, New York
Obe-cel in Severe, Refractory Systemic Lupus Erythematosus (SLE) With Active Lupus Nephritis (LN)
RekruttererFase 2
- Icahn School of Medicine at Mount Sinai, New York
Effects of Stopping Hydroxychloroquine in Elderly Lupus Disease
RekruttererFase 3
- VA NY Harbor Healthcare System, New York
- NYC Health + Hospitals/Bellevue, New York
- NYU Langone Health, New York
- og 2 flere
Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty
RekruttererFase 2
- NYU Langone Health, New York
A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Systemic Lupus Erythematosus
RekruttererFase 1
- Columbia University Medical Center, New York
A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
RekruttererFase 1
- Montefiore Medical Center, New York
Predictors of Pregnancy Outcome in Systemic Lupus Erythematosus (SLE) and Antiphospholipid Syndrome (APS)
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- NYU Langone Medical Center/Hospital for Joint Diseases, New York
- Hospital for Special Surgery, New York
Alnuctamab for Refractory SLE (LATTE Study)
RekruttererFase 1
- Icahn School of Medicine at Mount Sinai, New York
Lupus Landmark Study: A Prospective Registry and Biorepository
RekruttererObservasjonsstudie
- Columbia University Medical Center, New York
- Northwell Health, New York
Safety of the Herpes Zoster Subunit Vaccine in Lupus
RekruttererFase 4
- NYU Langone Health, New York
Safety and Efficacy of ONT01 in Lupus
RekruttererTidlig fase 1
- Hospital for Special Surgery, New York
Lupus-studier i andre byer
- Houston, TX13 studier
- Durham, NC12 studier
- Miami, FL11 studier
- Washington, DC10 studier
- Tampa, FL9 studier
- Philadelphia, PA9 studier
- Clearwater, FL8 studier
- Santa Monica, CA8 studier
- Oklahoma City, OK8 studier
- Los Angeles, CA8 studier
- Chicago, IL8 studier
- Boston, MA8 studier
Andre studier i New York City
- Brystkreft136 studier
- Ikke-småcellet lungekreft121 studier
- Kreft (alle typer)109 studier
- Prostatakreft103 studier
- Metastatisk kreft93 studier
- Kolorektal kreft78 studier
- Eggstokkreft69 studier
- Lungekreft60 studier
- Multipelt myelom60 studier
- Pankreaskreft60 studier
- Endometriekreft52 studier
- Akut myelogen leukemi51 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.